Chief Medical Officer · BioAge Labs, Inc. (BIOA)

Paul Rubin

Paul Rubin, Chief Medical Officer of BioAge Labs, Inc., received total compensation of $1,476,080 for fiscal year 2025. This amount includes a base salary of $520,200, cash bonus/incentive of $208,080, and stock-based compensation of $732,600.

A named executive officer of BioAge Labs in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,476,080

FY2024: $1,923,841

Compensation figures as of the proxy filed April 21, 2026 (DEF 14A).

Paul Rubin compensation by year

BioAge Labs Summary Compensation Table · all 2 fiscal years held
In US dollars, as BioAge Labs reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$488,139$520,200
Bonus$0$0
Stock awards$0$0
Option awards$1,249,853$732,600
Non-equity incentive$170,849$208,080
Pension and deferred compensation$0$0
All other$15,000$15,200
Total$1,923,841$1,476,080

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BioAge Labs, Inc. DEF 14A filed April 21, 2026, accession 0001193125-26-166738, and prior-year filings. Open the filing on EDGAR.

$1.9M
$1.5M
FY24
FY25
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option154,167—$4.38
Option102,637—$8.39
Option8,558—$10.85
Option1,712—$6.57

Per the Outstanding Equity Awards at Fiscal Year-End table in BioAge Labs, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

BioAge Labs’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Kristen FortneyChief Executive Officer and President$2,886,590
Paul Rubin · this pageChief Medical Officer$1,476,080
Eric MorgenChief Operating Officer$1,447,240

The full BioAge Labs compensation record

free company brief

This page is one person within BioAge Labs's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BioAge Labs's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BioAge Labs's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy